Should Azithromycin No Longer Be Considered a Drug of Choice for Community- Acquired Pneumonia Because of Its Potential to Cause Cardiovascular Death?

Authors

  • Heather Kertland (Pro) St Michael’s Hospital, University of Toronto
  • Michael B Kays (Con) Purdue University College of Pharmacy

DOI:

https://doi.org/10.4212/cjhp.v66i5.1292

Abstract

-

Downloads

Download data is not yet available.

Downloads

Published

2013-10-22

Issue

Vol. 66 No. 5 (2013)

Section

Point Counterpoint / Le pour et le contre

License

Copyright © Canadian Society of Healthcare-Systems Pharmacy.

After publication of a manuscript in the CJHP, the authors of the manuscript must obtain written permission from the CSHP (publications@cshp.ca) before reproducing any text, figures, tables, or illustrations from the work in future works of their own. If a submitted manuscript is declined for publication in the CJHP, all said rights shall revert to the authors. Please note that any forms (e.g., preprinted orders and patient intake forms) used by a specific hospital or other health care facility and included as illustrative material with a manuscript are exempt from this copyright transfer. The CJHP will require a letter from the hospital or health care facility granting permission to publish the document(s).